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Testing Chemotherapeutic Agents in the Feather
Follicle Identifies a Selective Blockade of Cell
Proliferation and a Key Role for Sonic Hedgehog
Signaling in Chemotherapy-Induced Tissue Damage
Guojiang Xie1,5, Hangwei Wang1,5, Zhipeng Yan1, Linyan Cai1, Guixuan Zhou1, Wanzhong He2, Ralf Paus3,4
and Zhicao Yue1
Chemotherapeutic agents induce complex tissue responses in vivo and damage normal organ functions. Here we
use the feather follicle to investigate details of this damage response. We show that cyclophosphamide
treatment, which causes chemotherapy-induced alopecia in mice and man, induces distinct defects in feather
formation: feather branching is transiently and reversibly disrupted, thus leaving a morphological record of the
impact of chemotherapeutic agents, whereas the rachis (feather axis) remains unperturbed. Similar defects are
observed in feathers treated with 5-fluorouracil or taxol but not with doxorubicin or arabinofuranosyl cytidine
(Ara-C). Selective blockade of cell proliferation was seen in the feather branching area, along with a
downregulation of sonic hedgehog (Shh) transcription, but not in the equally proliferative rachis. Local delivery
of the Shh inhibitor, cyclopamine, or Shh silencing both recapitulated this effect. In mouse hair follicles, those
chemotherapeutic agents that disrupted feather formation also downregulated Shh gene expression and induced
hair loss, whereas doxorubicin or Ara-C did not. Our results reveal a mechanism through which chemo-
therapeutic agents damage rapidly proliferating epithelial tissue, namely via the cell population–specific,
Shh-dependent inhibition of proliferation. This mechanism may be targeted by future strategies to manage
chemotherapy-induced tissue damage.
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INTRODUCTION
Chemotherapy often damages normal tissue as an adverse
effect. Commonly used chemotherapeutic agents such as
cyclophosphamide (CYP), 5-fluorouracil (5-FU), taxol, and
doxorubicin (Dox) are believed to be toxic to all mitotic cells.
Chemotherapy-induced alopecia (CIA) is common in human
patients (Hesketh et al., 2004; Yun and Kim, 2007; Trueb,
2009; Chon et al., 2012), and rodent models have been
developed to study the molecular mechanism of chemo-
therapy-induced tissue damage (Hussein et al., 1990;
Botchkarev et al., 2000; Sharov et al., 2004; Jimenez et al.,
2008; Paus et al., 1994; 2013). A p53-dependent apoptosis
program, which likely involves Fas-dependent signaling
events, was suggested to underlie CIA (Botchkarev et al.,
2000; Sharov et al., 2004). Other molecules such as
ectodysplasin A receptor, epidermal growth factor receptor,
and the eukaryotic initiation factor 4E have also been
implicated (Brosh et al., 2010; Bichsel et al., 2013; Nasr
et al., 2013; Paik et al., 2013).
It is likely that cells interact with chemotherapeutic agents
in complex ways. For example, in addition to undergoing
apoptosis, cells may ‘‘slip’’ out of the cell cycle and thus
escape apoptosis (Gascoigne and Taylor, 2008). Also, cell-to-
cell variation in response to apoptosis-inducing agents can
arise from transcriptional differences (Spencer et al., 2009;
Ooi and Ma, 2013). Furthermore, because of the diverse
mechanisms of action, it is difficult to rationally predict
whether a specific chemotherapeutic agent will cause CIA in
a given patient (Hesketh et al., 2004; Yun and Kim, 2007;
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Trueb, 2009, Chon et al., 2012; Paus et al., 2013). Detailed
in vivo investigation in appropriate model systems therefore is
required to evaluate the alopecia-inducing potential of each
specific drug.
In this context, we hypothesized that fundamental and
translationally relevant mechanistic insights might be won
from studying the feather follicle. Like its distant mammalian
relative, the hair follicle, this characteristic avian skin appen-
dage represents a prototypic, cyclically regenerating minior-
gan in which complex ectodermal–mesodermal interactions
and stem cell biology can be studied exemplarily (Chuong
1998; Lin et al., 2013). Structurally, feathers display a regular
branching epithelium (barbs) attached to a central axis
(rachis), with smaller branches (barbules) protruding from
each barb (Lin et al., 2013; Yu et al., 2004; Prum and
Williamson, 2001; Figure 1a–c). The formation of these
structures is regulated by a set of evolutionarily conserved
molecular pathways. BMP/Noggin and Shh signaling are
involved (Yu et al., 2002; Harris et al., 2002; Chang et al.,
2004), and a Wnt signaling gradient controls the orientation of
the branching (Yue et al., 2006). The same signaling pathways
have long been known to be key players in hair follicle
development and cycling (St-Jacques et al., 1998; Chiang
et al., 1999; Botchkarev et al., 2001; Plikus et al., 2008, 2011;
Schneider et al., 2009).
Thus, as long as any relevance of concepts emanating
from feather model–based research for hair research
can be documented, the feather follicle may become an as
yet untapped resource for dissecting selected mole-
cular aspects of CIA pathology. Here, we have tested the
impact of chemotherapeutic agents on the developing
and cycling feather follicle and have compared this with
murine CIA.
RESULTS
CYP treatment induces defects in feather formation
Active feather growth was induced in 6-month-old adult
chicken by plucking and regeneration (Chen et al., 2014).
Adapting the established protocol of inducing complete
alopecia in mice by CYP (Paus et al., 1994), we found
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Figure 1. CYP disrupts feather formation. (a and b) Schematics showing the feather structure with barbs attach to the rachis, and barbules attach to barbs. The drug
effect will be recorded in the morphology as the feather grows. ra, rachis; cl, collar where feather branching has not started. (c) A normal feather. (d–f)
Representative examples of the feather morphology after CYP treatment. Showing the different grades of damage. The ‘‘intermediate’’ phenotype reveals that the
barbs are broken down, which then leads to grade II defect. White bracket indicates the interval of drug perturbation. Bar¼ 1 cm. (g) Feather phenotypes showing
the ‘‘population variation’’ among different birds and ‘‘individual variation’’ on the same bird (n is the number of feathers analyzed; each line represents one bird).
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significant defects in feather formation (Figure 1d–f). These
defects can be graded into two subtypes (Chen et al., 2014).
Grade I defects take a linear shape (Figure 1d): the feather
barbs persist without barbules attached in short intervals. This
specific type of feather defect is known as ‘‘isochrones,’’
meaning cells on this line are born at the same time: typically
such a line forms in the feather when a bird experiences a
short period of stress/starvation or ingests food with pigmenta-
tion-inducing properties (Lucas and Stettenheim, 1972; Prum
and Williamson, 2001). Grade II defects are more severe. The
lower edge of the defect remains a line, but the upper edge
takes a ‘‘V’’ shape (Figure 1f). There are feathers showing an
intermediate phenotype, which also reveals how grade II
defect arises: some barbs remain but with no barbules
attached in a short interval (Figure 1e). In all feathers, the
central shafts (rachis) remain unaffected. Therefore, unlike
mouse hair during CIA, feathers do not fall-out and finish their
growth cycle normally.
Variation in the feather phenotype was seen both among
different birds (population variation) and among different
feathers in a single bird (individual variation; Figure 1g). About
25–50% of the feathers remained normal. These results suggest
an effect independent of genetic backgrounds, and that the
response of the feather to chemotherapy varies significantly,
just as is typically seen with different hair follicles in mice and
man (Yun and Kim 2007, Chon et al., 2012, Paus et al., 2013).
CYP treatment selectively disrupts the feather structure and
induces intrafollicular apoptosis
Histological analysis revealed additional defects in feather
formation after CYP treatment (Figure 2a and b). At day 1 post
treatment (T1), the branching epithelium was already reduced.
This became more obvious at day 2 (T2). Again, variation in
response was noticed. In all cases, the rachis remained largely
normal, whereas the branching barbs/barbules were reduced
or disrupted in patterning, suggesting selective perturbation of
the feather structure (Figure 2b). In some cases, we noticed
disrupted feather branching similar to those observed after
ionizing radiation treatment (Figure 2b and Supplementary
Figure S1 online; Chen et al., 2014), suggesting an impact of
cytokine signaling. Indeed, an increased expression of TNFa
and IFNg in the feather follicles was noticed (Supplementary
Figure S1 online). This is well in line with previous studies
documenting altered cytokine production in human scalp hair
follicles treated with a CYP derivative (Bodo et al., 2007) and
with the fact that anti-inflammatory hormone treatment
significantly modulates the response of human hair follicles
to chemotherapy-induced damage in vitro (Bodo et al., 2009).
The reduced formation of feather branching could be due to
reduced cell proliferation (see below) or increased cell
apoptosis. Intrafollicular apoptosis is a major event during
CIA (Lindner et al., 1997, Botchkarev et al., 2000; Sharov
et al., 2004; Bodo et al., 2007; Paus et al., 1994; 2013).
Therefore, apoptosis in feather follicles was investigated with
the DNA binding dye propidium iodide (PI). Apoptotic cells
showed punctuated nuclei, which became obvious only in the
branching area at T1 or T2 (Figure 2c). Per each barb there
were 3–5 apoptotic cells, whereas no apoptotic cells were
seen in the rachis. Increased apoptosis in the branching area,
but very little in the rachis, was also demonstrated by terminal
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)
(Figure 3a and d).
Transmission electron microscopy (TEM) analysis remains
the ‘‘gold standard’’ of cytomorphological evidence for cell
apoptosis (Magerl et al., 2001; Bodo et al., 2007; Elmore,
2007). Again, this demonstrated normal euchromatin ultra-
structure in the nuclei of rachis cells, whereas isolated cells in
the branching area showed typical condensed hetero-
chromatin, and/or apoptotic bodies (Figure 2d). This confirms
that chemotherapy prominently induces apoptosis in distinct
compartments of the feather follicle epithelium, thus docu-
menting another parallel between the feather and hair follicle
response to chemotherapy.
CYP treatment induces distinct molecular and cellular
perturbations in the feather follicle
P53 activation and cell apoptosis are important in CIA
(Botchkarev et al., 2000; Sharov et al., 2004; Paus et al.,
2013). We demonstrated the activation of P53 by CYP, which
promoted nuclear enrichment of this protein both in the
branching area and the rachis (Figure 3a). RT-PCR (reverse
transcription-PCR) analysis showed increased expression of
p53/p21, indicating activation of the P53 signaling pathway
(Figure 3b and Supplementary Figure S4 online).
Other complex phenomena of drug-induced DNA damage
and repair responses are also documented in the feather
model. g-H2AX immunostaining, which indicated chromatin
modification after DNA damage, was increased (Figure 3a).
Moreover, we found extensive nuclear localization of poly
ADP-ribose polymerase (PARP) after CYP treatment. PARP is
involved in DNA damage repair and serving as a substrate for
caspase-3 during apoptosis (Wang et al., 1997; Liu et al.,
2011). Fas/Caspase-3 gene expression was increased, as
expected (Figure 3b and Supplementary Figure S4 online).
Together, feather follicles show typical responses to CYP
treatment on multiple molecular levels that are expected from
the hair research literature on CIA.
Selective inhibition of proliferation in the feather branching area
suggests a role for Shh signaling
Next, we analyzed cell proliferation in the feather follicles.
A significant reduction in proliferating cell nuclear antigen
(PCNA) immunoreactivity in the branching area, but not the
rachis, was observed (Figure 3a and c). To confirm a selective
blockade of cell proliferation, we examined (5-Bromo-2-
deoxyUridine) (BrdU) incorporation efficiency. Consistent
with previous work (Yue et al., 2005), most cells in the collar
and the branching area (ramogenic zone) actively proliferated.
After drug treatment, cells in the collar region still incorporated
BrdU but not cells in the ramogenic zone. Similarly, cells in the
rachis incorporated BrdU but not cells in the branching
epithelium (Figure 4c). Therefore, CYP blocks cell proliferation
only in the feather branching area. These results also explain
why feathers do not fall out after drug treatment, because the
rachises remain unaffected, and cells in the collar are able to
replenish the feather branching post treatment.
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This distinct proliferation phenotype suggested a possible
role of Shh signaling in mediating this damage. On one hand,
Shh signaling is critically involved in the control of epithelial
cell proliferation during feather/hair development and cycling
(Ting-Berreth and Chuong, 1996; St-Jacques et al., 1998;
Chiang et al., 1999; Botchkarev et al., 2001; Oro and
Higgins, 2003). On the other hand, Shh is not expressed in
the rachis or collar region (Figure 4a) but only in the branching
area where barb/barbule forms. Immunohistology confirmed
reduced expression of Shh after CYP treatment (Figure 4b):
Although Shh protein is normally expressed in the marginal
plate of the feather epithelium (i.e. between barbs), it was
undetectable 1 day post treatment. Reduced expression of Shh
mRNA, together with that of the downstream target genes
Cdc25, Nmyc, and Cyclin D1 (Benazeraf et al., 2006; Fan and
Khavari, 1999; Mill et al., 2005), was also confirmed
(Figure 3b and Supplementary Figure S4 online).
Redistribution of the topobiologically important adhesion
molecules, liver cell adhesion molecule (LCAM) and neural
cell adhesion molecule (NCAM) (Chuong and Edelman, 1985;
Lin et al., 2013), was also observed (Figure 4b). Given that
NCAM is not only important for feather development, but also
involved in the control of murine hair follicle cycling
(Combates et al., 1997; Mu¨ller-Ro¨ver et al., 1998) and that
NCAM expression in the dermal papilla is greatly reduced in
defective murine hair follicles (Panteleyev et al., 1999), this
reveals yet another parallel between the damage responses of
feather and hair.
Downregulation of Shh signaling recapitulates the effect of CYP
treatment in feather formation
To demonstrate that indeed downregulation of Shh signaling
could contribute to CYP-induced defects, we directly manipu-
lated Shh signaling in the feather follicle. Two independent
methods were applied, and similar results were obtained.
(i) We delivered cyclopamine, a chemical inhibitor of Shh
signaling, into the developing feather follicles using an agarose
bead carrier (Yue et al., 2006; Chen et al., 2014). Cyclopamine
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Figure 2. Analysis of CYP-induced feather defects. (a and b) H and E analysis showing the reduced feather branching but normal rachis (ra) after CYP treatment.
The perturbed branching pattern is also shown. Two examples at day 2 post treatment (T2) are shown to illustrate the variation in response. T1, 1 day post
treatment. Boxed areas in (a) are shown at a higher magnification in (b). (c) Propidium iodide (PI) staining and (d) TEM analysis of the feather epithelium. Notice the
punctuated PI staining in T1 and T2 branching areas, euchromatin in rachis cell nucleus, apoptotic bodies or condensed nucleus, and membrane blebbing in
branching areas after CYP treatment. Bar¼ 100mm in (a, b), 20mm in (c), and 2mm in (d).
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caused specific defects in feather formation (Figure 5a). In the
perturbed area, the cell mass was significantly reduced with
no branching formation. Hematoxylin and eosin (H and E)
analysis confirmed this observation (Figure 5b). PCNA staining
revealed decreased cell proliferation in the perturbed area, as
compared with the neighboring branches (Figure 5c).
T0
P5
3
γ-
H
2A
X
PA
R
P
PC
NA
Ca
sp
as
e-
3
TU
NE
L
T0 T1
T124
22
Fo
ld
 c
ha
ng
e
ve
rv
u
s 
T0
2–2
2–4 Shh Fas P21 T0 T1 T2 T0 T1 T2
0
10
20
30
40
50
60
1
0
2
3
4
5
6
*
TUNEL
70
PCNA
***
***
PC
NA
-p
os
tiv
e 
ce
lls
 p
er
 b
ar
b
TU
NE
L-
po
st
ive
 c
el
ls 
pe
r b
ar
b
T2
T2
Shh
Fas
P21
Actin
T1 T2 Rachis T1
Figure 3. Molecular and cellular analysis in the feather follicle after CYP treatment. (a) Immunostaining of P53, g-H2AX, PARP, PCNA, Caspase-3, and
TUNEL staining in the feather follicle. Both the branching area (T1, T2) and the rachis (T1) are shown. CYP induces nuclear enrichment of P53 and activates
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independent experiments were shown, with each repeated three times. (c and d) Quantification of PCNA and TUNEL staining in feather branches (mean±SD).
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(ii) Using a recently developed method for lentiviral-
mediated gene silencing in the feather follicle (Chu et al.,
2014), RNAi-Shh delivery was shown to reduce the cell mass,
and no branching was formed in the perturbed area (Figure 5d
and e). The efficiency of RNAi knockdown was about 60%, as
monitored by quantitative PCR (qPCR) (Figure 5f). These
results suggest that downregulation of Shh signaling causes
defects in feather formation that are strikingly similar to those
induced by CYP treatment.
Chemotherapeutic agents differ in their capability to
downregulate Shh expression
To explore whether Shh signaling is universally perturbed by
chemotherapeutic agents or only specific to CYP, we tested
several other frontline drugs. Arabinofuranosyl Cytidine (Ara-
C) and Dox are often associated with P53 activation and cell
apoptosis. However, in our assays they did not disrupt feather
formation. Although previous work suggested that Dox at
15 mg kg1 i.p. injection induces alopecia in mice (Selleri
et al., 2005,2006; see below and Supplementary Figure S5
online), at this dose all chickens died. In contrast, 5-FU and
taxol induced feather defects (Figure 6a). Overall, 5-FU
induced defects in 90% of the feathers, whereas taxol was
much less potent, with only 10% of the feathers showing
grade I defect (Figure 6b).
Next, this selectivity in feather follicle damage was
correlated with the impact on intrafollicular Shh expression.
Ara-C- or Dox-treated feathers showed normal expression of
Shh protein, whereas in 5-FU or taxol-treated feathers, Shh
protein levels were significantly decreased (Figure 6c). There-
fore, downregulation of Shh gene expression correlated well
with morphological defects.
As 5-FU extensively damages feather formation, and
remains an important chemotherapeutic agent in cancer
therapy, we investigated its impact in the feather follicle
further (Supplementary Figure S2 online). Similar to CYP,
5-FU also activated P53 signaling and increased p53/p21
gene expression. g-H2AX and PARP were activated, both in
the branching area and the rachis. Downregulation of PCNA
staining was found only in the branching area, but not the
rachis, as expected. RT-PCR analysis confirmed downregula-
tion of Shh gene expression, together with that of the down-
stream target genes (Supplementary Figure S2 and S4 online).
However, 5-FU did not activate caspase-3 as strongly as CYP,
which correlated with weaker TUNEL signals. PI staining and
TEM analysis also revealed less apoptosis (Supplementary
Figure S3 online). These observations in the feather model
correspond well with the relatively lower incidence and
milder phenotype of CIA in patients treated with 5-FU (Alley
et al., 2002, Chon et al., 2012).
Key observations made in the feather model are reproduced in
murine hair follicles in vivo
Finally, we tested directly whether any of these observations in
the feather model is of relevance in mammalian skin biology,
using the best-established mouse model of CIA (Paus et al.,
1994). This showed that the capacity of a tested chemothera-
peutic drug to downregulate Shh gene expression correlated
well with its capability to induce hair loss (Figure 6d and e). At
the tested doses, 5-FU and Taxol induced significant hair loss
and downregulated Shh gene expression, which is in signifi-
cant contrast to Ara-C and Dox. On the other hand, the
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expression levels of p21 and Fas do not correlate with the hair
loss phenotype. At a higher dose, Dox treatment induced hair
loss in mice and downregulated Shh gene expression
(Supplementary Figure S5 online). These results suggest that
our observations made in the feather system may hold true in
murine hair follicles, and the key role of Shh signaling in
chemotherapy-induced feather follicle damage also applies to
mammalian skin appendages.
DISCUSSION
In this work, we show that despite its obvious distinctness, the
experimentally well-tractable feather follicle harbors impor-
tant lessons for hair follicle research and that the feather model
can reveal signaling pathways that had previously escaped
notice in CIA research (Chon et al., 2012; Paus et al., 2013).
We reveal that chemotherapeutic agents selectively disrupt a
defined portion of the adult feather structure and that
downregulation of Shh gene expression correlates with this
selectivity. As we show that some of these results are
reproducible in murine hair follicles in vivo, our findings are
likely to be relevant beyond avian biology and invite one to
explore targeting the Shh pathway as a potential strategy for
the future management of CIA.
Thus, despite the obvious differences between feather and
hair (Paus and Cotsarelis, 1999; Yu et al., 2004; Lin et al.,
2013), one can use the feather model to dissect general
principles that govern the complex effects of chemotherapy
reagents and other proliferation–/ apoptosis–inducing reagents
on epithelial growth control and regeneration. Interestingly,
the downregulation of Shh expression in chemotherapy-
treated feather follicles identified here is faithfully reflected
in murine anagen hair follicles treated with the same alopecia-
inducing chemotherapeutic agents. This underscores that the
feather follicle is indeed an excellent model for dissecting
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evolutionarily conserved damage-response pathways of verte-
brate skin appendages.
Shh signaling promotes hair regrowth in mice after CIA
(Sato et al., 2001), and Shh agonists are hair-growth promoting
(Paladini et al., 2005). Yet, the role of Shh signaling in
mediating chemotherapy-induced tissue damage as such had
not been investigated or even considered in CIA pathobiology
research (Paus et al., 2013). Obviously, before the potential
clinical relevance of our findings in feather and murine
hair follicles can be judged, the role of Shh signaling should
be further investigated in chemotherapy-damaged human
scalp hair follicles, using established in vitro (Bodo et al.,
2007) and in vivo systems (Paus et al., 2013) (see
Supplementary discussion online on chemotherapy dosage
considerations and interfollicular variations of the feather
response to chemotherapy).
The regulation of Shh gene expression in hair and feather
development remains incompletely understood. It is known
that ectodysplasin A/ectodysplasin A receptor and Wnt signal-
ing act upstream of Shh expression and that TNFa activates
Shh expression in embryonic skin (Schmidt-Ullrich et al.,
2006; Zhang et al., 2009). However, it is unclear whether
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there are hitherto unknown regulatory mechanisms under
pathological conditions that come along with the meta-
bolic cell stress and the generation of reactive oxygen
species induced by chemotherapeutic agents. Previous
work suggested antioxidants could ameliorate CIA
(reviewed in Wang et al., 2006; Trueb, 2009), and our
preliminary results suggest that reactive oxygen species may
downregulate Shh gene expression (not shown).
Downregulation of Shh gene expression is a rather quick
response by CYP treatment––i.e. within 24 hours Shh mRNA
was reduced to one fourth of the original level in the feather
follicle. Morphologically, this coincides with or precedes
obvious tissue damage both in feather (Figure 2) and hair
(Supplementary Figure S6 online). Therefore, an intraepithe-
lial mechanism appears to be in place that directly down-
regulates Shh gene expression. Subsequent studies are
required to clarify the upstream signaling cascades.
In summary, we propose an additional layer of complexity in
the pathobiology of chemotherapy-induced tissue damage by
introducing Shh–regulated proliferation control in distinct
epithelial cells. This pathomechanism may be targeted ther-
apeutically and likely requires an approach that is distinct from
the commonly discussed anti-apoptosis strategies for managing
CIA (Paus et al., 2013). Conceivably, this Shh-dependent
pathomechanism may extend to the chemotherapy response
of other tissues/organs. Furthermore, as we show here that not
all proliferating cells in the feather follicle will respond equally
to anti-proliferative, apoptosis-promoting chemotherapeutic
agents, one wonders if a similarly distinct, Shh-associated
response also occurs in cancer cells during chemotherapy.
MATERIALS AND METHODS
Experimental animals and procedures
Six months old male chickens (Gallus gallus domesticus) were bought
from a local farm maintained as an outbred stock. Male C57BL/6
mice were purchased from Shanghai SLAC animal facility center. All
experimental protocols were approved by Fuzhou University Experi-
mental Animal Ethics Board. Active feather growth was induced by a
plucking-regeneration protocol (Chen et al., 2014), and active hair
growth was induced as described previously (Paus et al., 1994). The
doses used were as follows: CYP (Sigma, Shanghai, China)
150 mg kg 1, Ara-C (Sigma) 50 mg kg 1, Doxorubicin (BBI,
Shanghai, China) 10 mg kg 1, 5-FU (Meryer, Shanghai, China)
150 mg kg 1, and Taxol (BBI) 100 mg kg 1. Feathers were each
individually marked and followed, and collected at designated
times for analysis, or left for another 3 weeks to finish the growth
cycle. For gene expression analysis in mice, whole skin samples
(5 5 mm) were collected at designated times.
Histology, immunostaining, and TUNEL staining
HE staining, immunostaining, TUNEL staining, and in situ hybridiza-
tions were processed as described (Chen et al., 2014). Briefly, feather
follicles were fixed by 4% paraformaldehyde at 4 1C overnight and
processed for paraffin section. For PI staining, sections were stained
with 1mgml 1 PI in PBS for 30 min and mounted. For BrdU
incorporation, animals were i.p. injected with 50 mg kg 1 BrdU
(Sigma) and samples collected 1 hour later. The following antibodies
were used: BrdU, Shh, LCAM, NCAM (Hybridoma Bank, Iowa City,
IA), P53, PARP, PCNA, Caspase-3 (Santa Cruz, Dallas, TX), and
g-H2AX (Abcam, Cambridge, UK).
TEM analysis
Feather samples were dissected and processed for ultrathin section
using the standard protocol. Briefly, samples were fixed with primary
fixative (0.2% tannic acid, 3% Tousimis glutaraldehyde in MOPS
buffer) and secondary fixative (1% OsO4 in water), stained with 2%
Ur-acetate, and mounted in resin. Ultrathin sections of 90 nm were
collected and examined under an FEI Tecnai G2 Spirit TEM.
RT-PCR and qPCR analysis
An average of four feather follicles were collected from the chicken at
designated times, and total RNAs extracted using the Trizol reagent
(Shanghai Sangon, Shanghai, China). Equal loading was monitored by
endogenous b-actin gene expression. For qPCR, each sample was
analyzed in triplicate using SYBR green (CWBIO, Beijing, China) and
a LightCycler480 real-time PCR machine (Roche, Basel, Switzerland).
Data are normalized to b-actin.
Lentivirus production and manipulation of feather growth in vivo
Lentivirus production and monitoring of RNAi efficiency were
described previously (Chu et al., 2014). Sequences targeted: Shh
(50-ttctcttggtgggcttca-30), and a random sequence was used as control
(50-agatacgacagaggacact-30). The efficiency of RNAi knockdown was
monitored in 293 T cells where a full-length chicken Shh gene was
stably transfected. Manipulation of feather growth by chemicals or
RNAi was described previously (Chen et al., 2014). Cyclopamine was
used at a final concentration of 500mM.
Statistics
Data were expressed as mean±SD. The statistical difference between
two groups was determined by the two-tailed t-test, and the P-value
was calculated.
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